833 abstracts found.



Results filter

Secreted frizzled related protein 4 (SFRP4) as an epigenetic biomarker of colorectal cancer risk

Year:

Session type:

Helen Staley1,2, David Bradburn2, John Mathers1
1Human Nutrition Research Centre, Institute of Ageing and Health, Newcastle University, Newcastle, UK, 2Wansbeck General Hospital, Northumberland, UK

Pre-testing the EORTC QLQ-ELD15 in patients aged 70 years and above with a haematological malignancy

Year:

Session type:

Colin Johnson1, Sally Wheelwright1, Deborah Fitzsimmons2, Teresa Young3
1University of Southampton, Southampton, UK, 2University of Swansea, Swansea, UK, 3Mount Vernon Hospital, Northwood, UK

Where do cancer patients die? An 18-year trend in England

Year:

Session type:

Yuen King Ho1, Wei Gao1, Julia Verne2, Myer Glickman3, Irene Higginson1
1King's College London, London, UK, 2South West Public Health Observatory, Bristol, UK, 3Office for National Statistics, Newport, UK

Day case management of malignant ascites

Year:

Session type:

Alison Stillie1, Kaiping Lin2, Clare Flood2, Deep Sarode2, Carl Mulholland2, Nicole Haggarty2, Laura McKelvey2, Daniel Greenwood2, Grace Shaw2, Maureen Gallanagh1
1Edinburgh Cancer Centre, Edinburgh, UK, 2University of Edinburgh Undergraduate Medical School, Edinburgh, UK

One year survival for ovarian cancer in the Yorkshire Cancer Network (YCN); improvement in the past decade

Year:

Session type:

Michael Crawford1, Ariadni Aravani2, Sarah Lawton2
1Airedale General Hospital, West Yorkshire, UK, 2NYCRIS, West Yorkshire, UK

Hydration status in advanced cancer patients: assessment of a novel evaluation technique

Year:

Session type:

Amara Nwosu1, Catriona Mayland1,2, Stephen Mason1, John Ellershaw1, Andrea Varro3
MCPCILMarie Curie Palliative Care Institute Liverpool, 2Aintree University Hospital NHS Foundation Trust, Liverpool, UK, 3Institute of Translational Medicine, University of Liverpool, Liverpool, UK

Consenting for Chemotherapy

Year:

Session type:

Dionysis Papadatos-Pastos1, Doraid Al-Rifai1, Dave Bell1, Cia Sinclair1, Dianne O'Connor1, Lisa Pickering1,2
1St George's Healthcare NHS Trust, London, UK, 2Royal Marsden Hospital, London, UK

Characteristics of cohort and baseline findings:  A cohort study to explore recovery of health and well-being following primary treatment of colo-rectal cancer (CREW (ColoRectal Wellbeing) cohort)

Year:

Session type:

Debbie Fenlon2, Kim Chivers Seymour1, Alison Richardson3,2, Julia Addington-Hall2, Peter Smith4, Jessica Corner2, Jane Winter3, Claire Foster1, Chloe Grimmett1
1Macmillan Survivorship Research Group, University of Southampton, Southampton, UK, 2Faculty of Health Sciences, University of Southampton, Southampton, UK, 3Southampton General Hospital,University Hospital Southampton NHS Foundation Trust, Southampton, UK, 4Southampton Statistical Sciences Research Institute, University of Southampton, Southampton, UK

Risk adjustment breast cancer follow up – Could Nottingham Prognostic Index (NPI) Predict Survival and Treatment Morbidity?

Year:

Session type:

P. Donnelly1, C. Lagord2, G. Lawrence2
1South Devon Health Care Trust, Devon, UK, 2West Midlands Cancer Intelligence Unit, Birmingham, UK

A comparison of tumour and host prognostic factors in screen detected versus non-screen detected colorectal cancer; a contemporaneous study

Year:

Session type:

David Mansouri1, Donald C McMillan1, Emilia M Crighton2, Paul G Horgan1
1Academic Department of Surgery, University of Glasgow,, Glasgow, UK, 2Public Health Screening Unit, NHS Greater Glasgow & Clyde,, Glasgow, UK

Variation in satisfaction with involvement in decisions about cancer treatment: analysis of the National Cancer Experience Survey 2012

Year:

Session type:

A. El Turabi1, G. Abel1, G. Lyratzopoulos1
1Cambridge Centre for Health Services Research, Cambridge, UK

Public attitudes and cancer beliefs in Northern Ireland: a study of the International Cancer Benchmarking Partnership

Year:

Session type:

A. Gavin1,2, C. Donnelly1,2, D. Donnelly1,2, M. Donnelly3
1Northern Ireland Cancer Registry, Belfast, UK, 2Queen's Unversity Belfast, Belfast, UK, 3Centre for Public Health, Queen's University Belfast, Belfast, UK

A Mobile Lymphoedema Clinic: Extending Lymphoedema Services Across Wales

Year:

Session type:

Rachel Iredale1, Richard Pugh1, Jenny Hilgart2, Melanie Lewis3
1Tenovus, the cancer charity, Wales, UK, 2Cardiff University, Cardiff, UK, 3Welsh Government, Wales, UK

Extending the operating hours of a freephone charity support line for cancer patients

Year:

Session type:

Rachel Iredale1, Rhiannon Skilton1, Jane Bridgeman1, Sharon Topazio1
1Tenovus, the cancer charity, Wales, UK

Developing Cancer Outreach Services in Wales

Year:

Session type:

Rachel Iredale1, Sharon Topazio1, Rhiannon Skilton1
1Tenovus, the cancer charity, Wales, UK

A survey to find out what people know about cancer research

Year:

Session type:

Sophie Gasson1, David Chuter1, Maggie Wilcox1
1SWSH CRN, Surrey, West Sussex and Hampshire, UK

LTC-IC: an in vitro model to study the role of the Notch pathway in the cross talk between Hematopoietic Stem Cells (HSCs) and their microenvironment.

Year:

Session type:

Alessandra Audia1, Fernando Anjos-Afonso1, Dominique Bonnet1
1London research Institute, London, UK

A retrospective study of metastasectomy in metastatic renal cell carcinoma  A retrospective study of metastasectomy in metastatic renal cell carcinoma Suder A1,Thillai K1, Rudman S1, Chandra A2, Rottenberg G3, Challacombe B4, Kooiman G5, Srinivasan, P6,  O’Brien T4, Chowdhury S1,5

Year:

Session type:

Aneta Suder1, Kiruthika Thillai1, Sarah Rudman1, A Chandra2, Giles Rottenberg3, Benjamin Challacombe4, Gordon Kooiman6, P Srinivasan5, Timothy O'Brien4, Simon Chowdhury1,6
1Department of Medical Oncology, Guys Hospital, London, UK, 2Department of Pathology, Guys Hospital, London, UK, 3Department of Radiology, Guys Hospital, London, UK, 4Department of Urology, Guys Hospital, London, UK, 5Institute of Liver Studies, Kings College Hospital, London, UK, 6Department of Urology, Kings College Hospital, London, UK

‘Sometimes It’s Cancer’ – Raising Awareness of Teenage and Young Adult Cancer in higher education students

Year:

Session type:

Kate Vaughan1, Sam Smith2, Amy Harding2, Lorraine Wright3, Martin McCabe1,3
1University of Manchester, Manchester, UK, 2Teenage Cancer Trust, London, UK, 3The Christie NHS Foundation Trust, Manchester, UK

Cancer awareness among adolescents in Britain: a cross-sectional study

Year:

Session type:

Richard Kyle1, Amy Harding2, Nigel Revell2, Liz Forbat1, Gill Hubbard1
1Cancer Care Research Centre, University of Stirling, Stirling, UK, 2Teenage Cancer Trust, London, UK

Let’s Talk About It: Evaluation of a school-based cancer awareness education programme delivered by Teenage Cancer Trust in the UK

Year:

Session type:

Amy Harding1, Nigel Revell1, Gill Hubbard2, Richard Kyle2
1Teenage Cancer Trust, London, UK, 2University of Stirling, Stirling, UK

Increased cancer awareness among British adolescents after a school-based educational intervention: a quasi-experimental before-and-after study

Year:

Session type:

Nigel Revell1, Gill Hubbard2, Amy Harding1, Liz Forbat2, Richard Kyle2
1Teenage Cancer Trust, London, UK, 2Cancer Care Research Centre, University of Stirling, Stirling, UK

A public engagement course that links directly to a public engagement event – feedback from the first year.

Year:

Session type:

Martin Christlieb1, Charlotte Richards2
1Department of Oncology, University of Oxford, Oxford, UK, 2Oxford Cancer Research Centre, Oxford, UK

Accessing Cancer Drugs on the Grounds of Exceptionality – Should Social Factors Matter?

Year:

Session type:

A Ford1,2
1School of Law, University of Manchester, Manchester, UK, 2Clatterbridge Cancer Centre, Merseyside, UK

Networking Senior Clinical Leaders in the National Institute for Health Research Cancer Research Network (NCRN)

Year:

Session type:

Helen Graham1, Sarah Kent1, Alison Clarke1, Jodi Baxter1, Anne Haldeos1, Sharai Chitando1, Linda Dawson-Athey1, Nicola Southwell1, Sandie Wellman1, Jackie Sears1, Karen Poole1
NCRNNational Institute for Health Resarch Cancer Research Network

Promoting Excellence in Investigator Sponsored Research: The Investigator Initiated-Sponsored Research Association (IISRA)

Year:

Session type:

Jonathan Chambers1
1Pierre Fabre Ltd, IISRA, Winchester, UK

Do patients who enter breast cancer research trials differ from those who don’t?

Year:

Session type:

Adrian Murray Brunt1, Caroline Hart1, Victoria Hoptroff1, Antonia Walchester1, marion Evans1
1University Hospital of North Staffordshire, Stoke-on-Trent, UK

Patient Experiences of Cancer Follow Up in Primary Care: a Qualitative Study

Year:

Session type:

Nicholas Denny1
1Oxford University, Oxford, OXON, UK

Increasing patient recruitment – the use of local media in clinical trials

Year:

Session type:

Paula Strider1
1York Teaching Hospital NHS Foundation Trust, York, UK

Patients’ willingness to engage with information about emotional reactions to cancer through the first 18 months post-diagnosis: A qualitative study of breast, lung and prostate cancer patients.

Year:

Session type:

Paul D. Baker1, Helen Beesley2, Robert Dinwoodie1, Ian Fletcher1, Janice Ablett2, Christopher Holcombe2, Peter Salmon1
1University of Liverpool, Liverpool, UK, 2Royal Liverpool University Hospital, Liverpool, UK

Developing a counselling service for cancer patients across Wales

Year:

Session type:

Rachel Iredale1, Helen French1
1Tenovus, the cancer charity, Wales, UK

A Phase I Trial of Bortezomib in Combination with Epirubicin, Carboplatin and Capecitabine (ECarboX) in Advanced Gastric and Gastro-oesophageal Junction (GOJ) Adenocarcinoma.

Year:

Session type:

Richard Turkington1,2, Colin Purcell2, Richard Wilson1,2, Martin Eatock2
1Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, Northern Ireland, UK, 2Northern Ireland Cancer Centre, Belfast, Northern Ireland, UK

Initiatives to improve breast screening uptake in London

Year:

Session type:

J. Offman1, S. Ariyanayagam2, M. Cruice3, A. Garner3, S. Sanghera3, S. Shiel4, M. Luck5, M. Farmer3, C. Bailey6, A. O'Neill7, D. Brazil8, L. Wilkinson9, G. Holdsworth10, T. Djuretic7, R. Jefferies3, K. Bynish11, S.W. Duffy1
1Centre for Cancer Prevention, London, UK, 2Queen Mary University of London, London, UK, 3NHS East London and the City, London, UK, 4Central and East London Breast Screening Service, London, UK, 5NHS Camden, London, UK, 6CNS Breast Screening, London, UK, 7NHS North Central London, London, UK, 8North London Breast Screening Service, London, UK, 9St Georges Healthcare NHS Trust, London, UK, 10NHS South East London, London, UK, 11London Quality Assurance Reference Centre, NHS Cancer Screening Programmes, London, UK

The influence of obesity and other essential comorbidities on lung cancer

Year:

Session type:

Nicosha De Souza1, Michael Marcus1, Ying Chen1, Olaide Raji1, Russell Hyde1, John K Field1
1University Of Liverpool, Liverpool, UK

Increasing the uptake of breast screening services by African Caribbean women in South East London through patient navigation

Year:

Session type:

M. Raime1
1Betterdays Cancer Care, London, UK

Chromosome segregation 1-like (CSE1L) gene is a key regulator of apoptosis, cellular adhesion and invasion in colorectal cancer

Year:

Session type:

Ayham Alnabulsi1, Abdelali Agouni1, Suman Mitra1, Isaac Garcia-Murillas2, Brian Carpenter1, Steve Bird1, Graeme Murray1
1University of Aberdeen, Aberdeen, UK, 2The Institute for Cancer Research, London, UK

Reaching women with effective breast awareness information – Touch look check

Year:

Session type:

S. Rawlings1, E. Hughes1, D. Gardner1, R. Greig1
1Breakthrough Breast Cancer, London, UK

Mammographic density and breast cancer risk in a young population at enhanced familial risk of breast cancer (FH01 study)

Year:

Session type:

Valentina Assi1, Stephen Duffy1, Jane Warwick2
1Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, UK, 2Imperial Clinical Trials Unit, Imperial College, London, UK

Core outcomes in late phase head and neck cancer clinical trials

Year:

Session type:

A. Waters1, C. Tudur-Smith1, T. Jones1, B. Young1
1University of Liverpool, Liverpool, UK

Tea and coffee and risk of endometrial cancer in postmenopausal women

Year:

Session type:

TienYu Owen Yang1, Francesca Crowe1, Benjamin J. Cairns1, Gillian K. Reeves1, Valerie Beral1
1Cancer Epidemiology Unit, University of Oxford, Oxford, UK

The COMET (Core Outcome Measures for Effectiveness Trials) Initiative: the importance of core outcome sets for practitioners, patients, policy makers and researchers

Year:

Session type:

P. Williamson1, D. Altman2, J. Blazeby3, M. Clarke4, E. Gargon1
1University of Liverpool, Liverpool, UK, 2University of Oxford, Oxford, UK, 3University of Bristol, Bristol, UK, 4Queen's University Belfast, Belfast, UK

Personalised screening for prostate cancer: cost-utility analysis

Year:

Session type:

Nora Pashayan1, Steve Morris1, Stephen W Duffy2, David E Neal3, Rosalind Eeles4, Douglas Easton3, Tom Dent5, Susmita Chowdhury5, Alison Hall5, Hilary Burton5, Paul DP Pharoah3
1University College London, London, UK, 2Queen Mary University of London, London, UK, 3University of Cambridge, Cambridge, UK, 4Institute of Cancer Research, London, UK, 5PHG Foundation, Cambridge, UK

Population based testing for inherited cancer predisposing BRCA 1/2 mutations is acceptable and detects’ at risk carriers without a strong family history of cancer

Year:

Session type:

Ranjit Manchanda1, Kelly Loggenberg1, Saskia Sanderson2, Matthew Burnell1, Jane Wardle3, Sue Gessler1, Lucy Side1, Nyala Balogun1, Rakshit Desai1, Ajith Kumar4, Huw Dorkins5, Yvonne Wallis6, Cyril Chapman7, Rohan Taylor8, Chris Jacobs9, Ian Tomlinson10, Alistair McGuire11, Uziel Beller12, Usha Menon1, Ian Jacobs13,1
1Dept Women's Cancer, EGA Institute for Women's Health, London, UK, 2Mt Sinai University, New York, USA, 3Behavioural Sciences Unit, Dept Epidemiology and Public Health, University College London, London, UK, 4Dept Clinical Genetics, North East Thames Regional Genetics Unit, Great Ormond Street Hospital, London, UK, 5Dept Clinical Genetics, North West Thames Regional Genetics Unit, Northwick Park Hospital, London, UK, 6West Midlands Regional Genetics Laboratory, Birmingham Women's NHS Foundation Trust, Birmingham, UK, 7Dept Clinical Genetics, West Midlands Regional Genetics Laboratory, Birmingham Women's NHS Foundation Trust, Birmingham, UK, 8South West Thames Molecular Genetics Diagnostic Laboratory, St George’s Hospital, London, UK, 9Dept Clinical Genetics, Guy’s Hospital, London, UK, 1010 London Research Institute, Cancer Research UK, London, UK, 11Dept. Health Economics, London School of Economics, London, UK, 12Dept Gynaecology, Shaare Zedek Medical Centre, Jerusalem, Israel, 13Faculty of Medical and Human Sciences, University of Manchester, Manchester, UK

Performance characteristics of ultrasound screening in the United Kingdom collaborative trial of ovarian cancer screening (UKCTOCS)

Year:

Session type:

Usha Menon1, Andy Ryan1, Stuart Campbell2, Marian Habib1, Sophia Apostolidou1, Aleksandra Gentry-Maharaj1, Matthew Burnell1, Jatinderpal Kalsi1, Aarti Sharma1, Naveena Singh3, Elizabeth Benjamin4, Gwendoline Fletcher1, Mourad Seif5, Nazar Amso6, Carol Burnel7, Gill Taylor8, Rani Rangar9, Keith Godfrey9, David Oram10, Jonathan Herod11
1Women’s Cancer, UCL EGA Institute for Women’s Health, London, UK, 2Create Health Clinics, 103-105 Harley Street, London, UK, 3Department of Pathology, Barts and the London, London, UK, 4Department of Pathology, UCL, London, UK, 5Academic Unit of Obstetrics and Gynaecology, St. Mary’s Hospital, Manchester, UK, 6Department of Obstetrics and Gynaecology, Wales College of Medicine, Cardiff University, Cardiff, UK, 7Department of Radiology, University College London Hospitals, London, UK, 8Department of Gynaecological Oncology, Derby City Hospital, Derby, UK, 9Northern Gynaecological Oncology Centre, Queen Elizabeth Hospital, Gateshead, UK, 10Department of Gynaecological Oncology, St. Bartholomew’s Hospital, London, UK, 11Department of Gynaecology, Liverpool Women’s Hospital, Liverpool, UK, 12Department of Gynaecological Oncology, Nottingham City Hospital, Nottingham, UK, 13Department of Gynaecological Oncology, Derby City Hospital, Derby, Derby, UK, 14Department of Gynaecological Oncology, Royal Free Hospital, London, UK, 15Department of Gynaecological Oncology, St Mary’s Hospital, Portsmouth, Portsmouth, UK, 16Department of Gynaecological Oncology, St Michael’s Hospital, Bristol, UK, 17Department of Gynaecological Oncology, Belfast City Hospital, Belfast, UK, 18Department of Gynaecological Oncology, Llandudno Hospital, LLandudno, UK, 19Department of Gynaecological Oncology, James Cook University Hospital, Middlesbrough, UK, 20Department of Medicine, Harvard Medical School, Boston, USA, 21Clinical Biochemistry, University College London Hospitals, London, UK, 22Cancer Research UK Sussex Psychosocial Oncology Group at Brighton & Sussex Medical School, University of Sussex, Falmer, UK, 23Cancer Group, Medical Research Council Clinical Trials Unit, London, UK, 24Faculty of Medical and Human Sciences, Innovation Centre, Core Technology Facility, The University of Manchester, Manchester, UK

Incidence of thyroid cancer in South Asians in England.

Year:

Session type:

Raghib Ali1, Isobel Barnes1, Shameq Sayeed1, Alexander Finlayson1
1Oxford University, Oxford, UK

Performance characteristics of multimodal screening with serum ca125 in the United Kingdom collaborative trial of ovarian cancer screening (UKCTOCS)

Year:

Session type:

Ian Jacobs1,22, Andy Ryan1, Steve Skates2, Mariam Habib1, Sophia Apostolidou2, Naveena Singh3, Elizabeth Benjamin4, Aleksandra Gentry-Maharaj1, Matthew Burnell1, Jatinderpal Kalsi1, Anne Dawnay1, Aatri Sharma1, Richard Gunu1, Keith Godfrey6, David Oram7, Jonathan Herod8, Karin Williamson9, Mourad Seif10, Howard Jenkins1, Tim Mould12, Robert Woolas13, John Murdoch14, Stephen Dobbs15
1Women’s Cancer, UCL EGA Institute for Women’s Health, London, UK, 2Department of Medicine, Harvard Medical School, Boston, USA, 3Department of Pathology, Barts and the London, London, UK, 4Department of Pathology, UCL, London, UK, 5Clinical Biochemistry, University College London Hospitals, London, UK, 6Northern Gynaecological Oncology Centre, Queen Elizabeth Hospital, Gateshead, UK, 7Department of Gynaecological Oncology, St. Bartholomew’s Hospital, London, UK, 8Department of Gynaecology, Liverpool Women’s Hospital, Liverpool, UK, 9Department of Gynaecological Oncology, Nottingham City Hospital, Nottingham, UK, 10Academic Unit of Obstetrics and Gynaecology, St. Mary’s Hospital, Manchester, UK, 11Department of Gynaecological Oncology, Derby City Hospital, Derby, UK, 12Department of Gynaecological Oncology, Royal Free Hospital, London, UK, 13Department of Gynaecological Oncology, St Mary’s Hospital, Portsmouth, Portsmouth, UK, 14Department of Gynaecological Oncology, St Michael’s Hospital, Bristol, UK, 15Department of Gynaecological Oncology, Belfast City Hospital, Belfast, UK, 16Department of Obstetrics and Gynaecology, Wales College of Medicine, Cardiff University, Cardiff, UK, 17Department of Gynaecological Oncology, Llandudno Hospital, Llandudno, UK, 18Department of Gynaecological Oncology, James Cook University Hospital, Middlesbrough, UK, 19Cancer Research UK Sussex Psychosocial Oncology Group at Brighton & Sussex Medical School, University of Sussex, Falmer, UK, 20Create Health Clinic, London, UK, 21Cancer Group, Medical Research Council Clinical Trials Unit, London, UK, 22Faculty of Medical and Human Sciences, The University of Manchester, Manchester, UK

Off protocol prescribing in oncology and haematology within NHS Tayside. An audit of the NHS Tayside oncology and haematology Medicines Management Group

Year:

Session type:

D. Dorward1, J. Dewar2, M. Parsons2
1University of Dundee, Dundee, UK, 2Ninewells Hospital, Dundee, UK

Use of cancer awareness measure to evaluate early diagnosis services

Year:

Session type:

T. Gorman1, N. Springham1, D. Howel2, S. Moffatt2
1NHS County Durham and Darlington, Durham, UK, 2Institute of Health and Society, Newcastle University, Newcastle, UK

Views of General Practitioners on use of cancer data; a qualitative study

Year:

Session type:

T. Gorman1, N. Springham1, S. Moffatt1
1NHS County Durham and Darlington, Durham, UK

Human Papillomavirus Integration as a Biomarker of Cervical Disease

Year:

Session type:

Rachel Raybould1, Sue Ashman1, Sadie Jones1, Jonathan Lippiatt1, Amanda Tristram1, Alison Fiander1, Sam Hibbitts1
1Cardiff University, Cardiff, UK